Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze WVE stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate WVE investment potential.

What is WVE stock price today?

Get real-time WVE stock price, historical data, and price charts on Financhill. Track WVE performance with our advanced analysis tools.

Is WVE a good investment?

Evaluate WVE investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy WVE stock?

To buy WVE stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of WVE?

View detailed market capitalization data and company valuation metrics for WVE on our comprehensive analysis page.

What is the P/E ratio of WVE?

Use our fundamental analysis tools to view WVE P/E ratio and compare valuation metrics with industry peers.

What are WVE earnings?

View WVE earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Wave Life Sciences Ltd. 10K Form

Sell

WVE
Wave Life Sciences Ltd.

Last Price:

$17.20

Seasonality Move:

-15.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09	10Q	WVE/Wave Life Sciences Ltd. Quarterly
2023-08-03	10Q	WVE/Wave Life Sciences Ltd. Quarterly
2023-05-03	10Q	WVE/Wave Life Sciences Ltd. Quarterly
2022-11-10	10Q	WVE/Wave Life Sciences Ltd. Quarterly
2022-08-11	10Q	WVE/Wave Life Sciences Ltd. Quarterly
2022-05-12	10Q	WVE/Wave Life Sciences Ltd. Quarterly

Receive WVE News And Ratings

See the #1 stock for the next 7 days that we like better than WVE

WVE Financial Statistics

Sales & Book Value

Annual Sales:	$108.3M
Cash Flow:	$-46.1M
Price / Cash Flow:	0
Annual Sales:	$0.78
Price / Book:	10.05

Profitability

EPS (TTM):	-0.74740
Net Income (TTM):	$-121.9M
Gross Margin:	$99.6M
Return on Equity:	-73.8%
Return on Assets:	-40.85%

Wave Life Sciences Ltd. Earnings Forecast

Key Wave Life Sciences Ltd. Financial Ratios

The Gross Profit Margin over the past 12 years for WVE is 92.00%.
The Selling, General & Administrative Expenses for WVE have been equal to 54.50% of Gross Profit Margin.
The Research & Development expenses have been 147.44% of Revenue.
The Net Earning history of WVE is -89.57% of Total Revenues.
Per Share Earnings over the last 12 years have been positive in 4 years.

Wave Life Sciences Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	WVE
CUSIP:	Y95308
Website:	wavelifesciences.com

Debt

Debt-to-Equity Ratio:	0.15
Current Ratio:	2.51
Quick Ratio:	2.4

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

WVE Technical Analysis vs Fundamental Analysis